177 related articles for article (PubMed ID: 32686837)
1. Androgenetic Complete Hydatidiform Moles With p57KIP2-Positive Immunostaining.
Usui H; Sato A; Ota M; Ikeda JI; Shozu M
Am J Clin Pathol; 2020 Nov; 154(6):776-783. PubMed ID: 32686837
[TBL] [Abstract][Full Text] [Related]
2. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
3. Recurrent Androgenetic Complete Hydatidiform Moles with p57
Li MW; Li F; Cheng J; Wang F; Zhou P
Reprod Sci; 2022 Jun; 29(6):1749-1755. PubMed ID: 34606065
[TBL] [Abstract][Full Text] [Related]
4. Auxiliary and experimental diagnostic techniques for hydatidiform moles.
Usui H
J Obstet Gynaecol Res; 2022 Dec; 48(12):3077-3086. PubMed ID: 36098274
[TBL] [Abstract][Full Text] [Related]
5. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
6. p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases.
Gaillot-Durand L; Patrier S; Aziza J; Devisme L; Riera AC; Marcorelles P; Pelluard F; Gasser B; Mauduit C; Hajri T; Massardier J; Bolze PA; Golfier F; Devouassoux-Shisheboran M; Allias F
Hum Pathol; 2020 Jul; 101():18-30. PubMed ID: 32387104
[TBL] [Abstract][Full Text] [Related]
7. P57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions.
Hoffner L; Dunn J; Esposito N; Macpherson T; Surti U
Hum Pathol; 2008 Jan; 39(1):63-72. PubMed ID: 17904617
[TBL] [Abstract][Full Text] [Related]
8. Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.
Xing D; Adams E; Huang J; Ronnett BM
Mod Pathol; 2021 May; 34(5):961-982. PubMed ID: 33024305
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping.
Banet N; DeScipio C; Murphy KM; Beierl K; Adams E; Vang R; Ronnett BM
Mod Pathol; 2014 Feb; 27(2):238-54. PubMed ID: 23887308
[TBL] [Abstract][Full Text] [Related]
10. [Histopathological features of hydatidiform moles and placenta changes of nonmolar miscarriage in early stage of pregnancy].
Dong Y; Zhang S; Wang ML; Guo H; Zhang Y; Wang Y; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):194-8. PubMed ID: 21503111
[TBL] [Abstract][Full Text] [Related]
11. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.
Jun SY; Ro JY; Kim KR
Histopathology; 2003 Jul; 43(1):17-25. PubMed ID: 12823708
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201
[TBL] [Abstract][Full Text] [Related]
13. Parental contribution to trisomy in heterozygous androgenetic complete moles.
Usui H; Sato A; Shozu M
Sci Rep; 2020 Oct; 10(1):17137. PubMed ID: 33051545
[TBL] [Abstract][Full Text] [Related]
14. Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.
Xing D; Miller K; Beierl K; Ronnett BM
Am J Surg Pathol; 2022 Jan; 46(1):18-32. PubMed ID: 34074808
[TBL] [Abstract][Full Text] [Related]
15. Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay.
Murphy KM; McConnell TG; Hafez MJ; Vang R; Ronnett BM
J Mol Diagn; 2009 Nov; 11(6):598-605. PubMed ID: 19815697
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists.
Gupta M; Vang R; Yemelyanova AV; Kurman RJ; Li FR; Maambo EC; Murphy KM; DeScipio C; Thompson CB; Ronnett BM
Am J Surg Pathol; 2012 Dec; 36(12):1747-60. PubMed ID: 22992698
[TBL] [Abstract][Full Text] [Related]
17. Gestational Trophoblastic Neoplasia From Genetically Confirmed Hydatidiform Moles: Prospective Observational Cohort Study.
Usui H; Qu J; Sato A; Pan Z; Mitsuhashi A; Matsui H; Shozu M
Int J Gynecol Cancer; 2018 Nov; 28(9):1772-1780. PubMed ID: 30358702
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterization of p57Kip2 expression in tetraploid hydropic placentas.
Fukunaga M
Arch Pathol Lab Med; 2004 Aug; 128(8):897-900. PubMed ID: 15270611
[TBL] [Abstract][Full Text] [Related]
19. Single-nucleotide polymorphism array and fluorescence in situ hybridization analysis to decode the cytogenetic profile of atypical partial hydatidiform moles diagnosed by short tandem repeat polymorphism analysis.
Suzuki Y; Usui H; Katayama E; Sato A; Nakamura N; Nakada E; Omoto A; Okayama J; Sato M; Nagasawa A; Hirosawa A; Shozu M; Koga K
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23220. PubMed ID: 38780072
[TBL] [Abstract][Full Text] [Related]
20. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
Sato A; Usui H; Shozu M
Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]